News
Astrix to acquire MAIN5 in undisclosed deal
- Segment
- Pharmaceutical Services
- Industry
- Tech
- Type
- acquisition
Astrix, a pharmaceutical technology services provider, has acquired MAIN5, also a pharmaceutical technology services provider. The deal value was not disclosed. Gibson Dunn advised Quad-C and its portfolio company Astrix on the transaction.
One of 124 Pharmaceutical Services deals Healthcare DealHub has tracked in 2026.
Source: Gibsondunn